Proteogenomic insights suggest druggable pathways in endometrial carcinomaYongchao Dou, Mehdi Mesri, Lizabeth Katsnelson et al.|Cancer Cell|2023Cited by 53
NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025Nadeem R. Abu‐Rustum, Vaishnavi Sambandam, Hye Sook Chon et al.|Journal of the National Comprehensive Cancer Network|2025Cited by 39
Inhibiting WNT Ligand Production for Improved Immune Recognition in the Ovarian Tumor MicroenvironmentWhitney N. Goldsberry, Rebecca C. Arend|Cancers|2020Cited by 27
Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In OncologyNadeem R. Abu‐Rustum, Vaishnavi Sambandam, Susana M. Campos et al.|Journal of the National Comprehensive Cancer Network|2025Cited by 11